Celularity, Inc. (CELU)
0.7748
-0.03
(-3.16%)
USD |
NASDAQ |
Aug 24, 16:00
0.7719
0.00 (0.00%)
After-Hours: 20:00
Celularity Gross Profit Margin (Quarterly) : -123.6% for Dec. 31, 2025
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | -123.6% |
| September 30, 2025 | -8.40% |
| June 30, 2025 | -23.36% |
| March 31, 2025 | 52.84% |
| December 31, 2024 | 49.16% |
| September 30, 2024 | 37.86% |
| June 30, 2024 | 65.99% |
| March 31, 2024 | 74.14% |
| December 31, 2023 | 1.71% |
| September 30, 2023 | -57.03% |
| June 30, 2023 | -6.33% |
| Date | Value |
|---|---|
| March 31, 2023 | -10.95% |
| December 31, 2022 | -86.15% |
| September 30, 2022 | -132.3% |
| June 30, 2022 | -45.60% |
| March 31, 2022 | -6.32% |
| December 31, 2021 | -49.60% |
| September 30, 2021 | 56.17% |
| June 30, 2021 | -5.44% |
| March 31, 2021 | -19.47% |
| December 31, 2020 | 7.40% |
| September 30, 2020 | 0.80% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | -- |
| Exicure, Inc. | -- |
| Century Therapeutics, Inc. | -- |
| Absci Corp. | -747.8% |
| Cardio Diagnostics Holdings, Inc. | -824.1% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -46.78% |
| Return on Invested Capital | -169.9% |
| Profit Margin (Quarterly) | -593.6% |
| Operating Margin (Quarterly) | -537.5% |
| Return on Net Operating Assets | -86.11% |